PT-141 Made in USA — Third-Party Verified
PX1 Research supplies high-purity, USA-synthesized PT-141 (Bremelanotide) specifically engineered for non-clinical laboratory applications. Every lot undergoes rigorous testing in an ISO 17025 accredited facility, ensuring verified purity and consistent potency for precise scientific investigation.
Quick answer
PX1 Research supplies high-purity, USA-synthesized PT-141 (Bremelanotide) specifically engineered for non-clinical laboratory applications. Every lot undergoes rigorous testing in an ISO 17025 accredited facility, ensuring verified purity and consistent potency for precise scientific investigation.
Key takeaways
- [PT-141](/research-peptides/pt-141), chemically designated as Bremelanotide, is a synthetic cyclic heptapeptide analog of naturally occurring alpha-melanocyte-stimulating hormone (alpha-MSH).
- [PT-141](/research-peptides/pt-141) functions as a potent, non-selective agonist across several sub-types of the melanocortin receptor (MCR) family.
- Preclinical rodent models have demonstrated that central administration of [PT-141](/research-peptides/pt-141) engages neural circuits responsible for complex behavioral responses.
- When designing comparative pharmacological experiments, researchers frequently evaluate [PT-141](/research-peptides/pt-141) alongside related structural analogs within the melanocortin agonist family.
Chemical Overview and Structural Configuration of PT-141
PT-141, chemically designated as Bremelanotide, is a synthetic cyclic heptapeptide analog of naturally occurring alpha-melanocyte-stimulating hormone (alpha-MSH). Structurally derived from Melanotan II, PT-141 features a modified lactam bridge structure with the sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH. The removal of the C-terminal amide moiety significantly modifies its pharmacological binding profile relative to precursor molecules, yielding a compound focused primarily on central melanocortin receptor activation.
In laboratory research environments, this structural stabilization enhances peptide resistance against enzymatic degradation by serum proteases. When investigators evaluate PT-141 peptide in biochemical or physiological assays, the cyclic lactam core provides predictable conformational stability. This structural integrity allows researchers to observe specific receptor kinetics without rapid non-specific enzymatic hydrolysis altering experimental parameters.
Melanocortin Receptor Binding Affinity and Selectivity Profiles
PT-141 functions as a potent, non-selective agonist across several sub-types of the melanocortin receptor (MCR) family. Preclinical studies indicate primary activity at the melanocortin-3 (MC3R) and melanocortin-4 (MC4R) receptors located within the central nervous system, alongside secondary binding at MC1R and MC5R. Unlike classical autonomic or vasoactive compounds, PT-141 does not directly act on vascular smooth muscle or peripheral adrenergic receptors.
Instead, the primary mechanism of action involves targeted interaction with central MC4R pathways within the hypothalamus. In vitro binding assays demonstrate that PT-141 binds with nanomolar affinity to human recombinant MC4R, initiating intracellular cyclic adenosine monophosphate (cAMP) accumulation through G-protein coupled receptor signaling cascades. Investigating these specific receptor dynamics provides insight into central pathways involved in autonomic response modulation.
Central Signaling Pathways Investigated in Preclinical Models
Preclinical rodent models have demonstrated that central administration of PT-141 engages neural circuits responsible for complex behavioral responses. Research indicates that activation of MC4R in the medial preoptic area (mPOA) and the paraventricular nucleus (PVN) of the hypothalamus plays a key role in central pathway mediation. This activity is investigated for melanocortin-receptor signaling linked to sexual-health pathways and neuroendocrine responses.
Unlike peripherally acting agents that operate via direct nitric oxide-mediated vasodilation, PT-141 acts upstream within the central nervous system. Downstream of central MC4R binding, neural signaling cascades trigger pro-erectile and motivational behavioral outputs in animal models. By isolating these pathways from vascular mechanisms, laboratory studies using PT-141 allow researchers to map central neurochemical responses independently of direct peripheral cardiovascular influences.
Comparative Analysis: PT-141 and Related Melanocortin Compounds
When designing comparative pharmacological experiments, researchers frequently evaluate PT-141 alongside related structural analogs within the melanocortin agonist family. Evaluating these distinct profiles assists labs in choosing appropriate reagents for receptor-specific binding models.
For instance, Melanotan II shares a similar cyclic structure with PT-141 but exhibits higher non-selective affinity for MC1R, resulting in prominent peripheral melanogenesis alongside central signaling. Conversely, Melanotan I acts as a selective MC1R agonist, primarily utilized in research evaluating integumentary pigmentation without triggering central MC4R-mediated responses. In contrast to native alpha-MSH analogs, PT-141 offers an extended biological half-life and central selectivity profile, making it a distinct reference compound in structural biology and neuroscience experiments. Explore our broader PX1 Research library for detailed comparative data across these candidate molecules.
Domestic Synthesis Standards: The Importance of USA Manufacturing
The integrity of preclinical trial data relies entirely on reagent purity, batch-to-batch consistency, and freedom from manufacturing contaminants. Obtaining pt-141 made in usa ensures that the synthesis process adheres strictly to rigorous domestic manufacturing standards. Overseas peptide production frequently suffers from inconsistent amino acid coupling, incomplete deprotection, and residual solvent contamination that can skew sensitive bioassays.
PX1 Research facilities utilize solid-phase peptide synthesis (SPPS) protocols conducted under controlled environmental conditions within the United States. Utilizing high-grade reagents and precision automated synthesizers, domestic production controls every reaction step—from Fmoc-deprotection to lactam ring cyclization—ensuring superior sequence fidelity and structural correctness for demanding scientific research.
Analytical Purity Verification: HPLC and Mass Spectrometry
Every production lot of PT-141 supplied by PX1 Research undergoes strict analytical verification prior to distribution. Purity is validated using High-Performance Liquid Chromatography (HPLC), which separates synthesis byproducts, truncation sequences, and residual reagents from the primary peptide peak. Only lots meeting or exceeding a baseline purity threshold of 99% are cleared for research deployment.
Complementing liquid chromatography, Electrospray Ionization Mass Spectrometry (ESI-MS) or Matrix-Assisted Laser Desorption/Ionization (MALDI-TOF) is performed to confirm the exact molecular weight of the peptide. Mass spectrometry guarantees that the target sequence (1024.2 Da nominal mass) is accurately formed with correct cyclization and protect-group removal. Comprehensive Certificates of Analysis (COA) detailing both HPLC chromatograms and mass spectra are provided with every batch.
Endotoxin Testing and ISO 17025 Laboratory Compliance
Bacterial endotoxins (lipopolysaccharides) introduce confounding inflammatory variables into cell culture assays and animal studies. Even high-purity peptides can harbor endotoxin contamination if processing water and equipment are not rigorously controlled. PX1 Research implements Chromogenic Reagent Limulus Amebocyte Lysate (LAL) testing to quantify endotoxin concentrations on every lot.
All analytical testing is executed through an independent, accredited ISO 17025 laboratory. This strict standard ensures that equipment calibration, analytical methods, and data logging meet internationally recognized standards. Researchers sourcing research peptides from PX1 receive fully traceable reagents optimized for sensitive in vitro assays where immunological contamination cannot be tolerated.
Laboratory Reconstitution, Storage, and Handling Guidelines
PT-141 is supplied as a lyophilized (freeze-dried) powder under vacuum or inert argon gas to preserve chemical stability during storage. Upon receipt, unopened vials should be stored in a freezer maintained at -20°C or lower, protected from light and moisture. Under these conditions, the lyophilized peptide maintains stability for extended periods.
For laboratory reconstitution, researchers should allow the vial to equilibrate to room temperature before adding a suitable solvent, such as sterile Bacteriostatic Water or phosphate-buffered saline (PBS). Gentle swirling is recommended to dissolve the cake completely; vigorous agitation or sonication should be avoided to prevent mechanical shearing of the cyclic structure. Once reconstituted, liquid solutions should be stored at 2°C to 8°C and used within a short timeframe, or aliquoted and frozen to prevent degradation from repeated freeze-thaw cycles.
Institutional Sourcing and High-Volume Laboratory Accounts
PX1 Research caters to the operational needs of university laboratories, contract research organizations (CROs), and private biotech firms requiring consistent supply chains. Orders placed Monday through Friday ship same-day from our primary logistics centers in California and Arizona, minimizing transit times and cold-chain exposure.
For high-throughput screening projects, long-term animal studies, or multi-center research programs requiring custom batch sizes or bulk procurement, institutional buyers can utilize our bulk lab ordering portal. Dedicated account managers assist research procurement teams with lot reservation, customized analytical testing, and bulk pricing schedules designed for large-scale institutional projects. Academic and commercial facilities can also explore adjacent research tools such as BPC-157 within our catalog.
Frequently Asked Questions
What is the primary mechanism of action of PT-141 in research models?
PT-141 (Bremelanotide) acts as a non-selective melanocortin receptor agonist, exhibiting primary binding activity at central MC3R and MC4R receptors within the hypothalamus. Preclinical studies show it activates central neurochemical signaling linked to sexual-health pathways without direct vascular action.
Where is PX1 Research's PT-141 synthesized?
PX1 Research's PT-141 is synthesized entirely within the United States using advanced solid-phase peptide synthesis (SPPS) in GMP-compliant manufacturing facilities.
How is the purity of PT-141 verified?
Purity is verified via High-Performance Liquid Chromatography (HPLC) to confirm sequence purity above 99%, while Mass Spectrometry (MS) verifies the exact molecular weight and cyclic structure. Testing is performed per lot by an independent ISO 17025 accredited laboratory.
What endotoxin limits are verified for PT-141 lots?
Every lot undergoes LAL endotoxin testing to confirm contamination levels fall below strict safety thresholds (typically < 0.01 EU/mg), ensuring compatibility with sensitive in vitro and animal research protocols.
How should lyophilized PT-141 be stored upon delivery?
Lyophilized PT-141 should be stored at -20°C or colder upon arrival, protected from direct light and ambient moisture. Stored properly, the dry powder remains stable for up to 24 months.
What solvents are recommended for reconstituting PT-141 in a lab setting?
Standard laboratory reconstitution utilizes sterile Bacteriostatic Water (0.9% benzyl alcohol) or sterile physiological saline (0.9% NaCl) depending on the intended experimental protocol.
How does PT-141 differ structural from Melanotan II?
PT-141 is a metabolite analog of Melanotan II where the C-terminal amide is replaced with a hydroxyl group. This modification significantly reduces binding affinity for melanogenesis pathways while retaining high selectivity for central nervous system MC3R and MC4R.
Where does PX1 Research ship PT-141 from?
All orders are processed and shipped directly from our domestic fulfillment centers located in California and Arizona, with same-day dispatch for orders placed Monday through Friday.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.